Moffat; David Festus Charles
Patent Applications and Registrations
Patent applications and USPTO patent grants for Moffat; David Festus Charles.The latest application filed is for "treatment of cancer by stimulation of il-12 production".
Company Profile
0.32.42
- Moffat; David Festus Charles - Windsor Berkshire GB
- Moffat; David Festus Charles - Abingdon GB
- Moffat; David Festus Charles - Oxfordshire GB
- Moffat; David Festus Charles - Berkshire GB
- Moffat, David Festus Charles - Maidenhead GB
- Moffat; David Festus Charles - Maidonhead GB
Patent Activity
| Patent | Date |
|---|---|
| Treatment of cancer by stimulation of IL-12 production Grant 11,382,902 - Moffat , et al. July 12, 2 | 2022-07-12 |
| Treatment Of Cancer By Stimulation Of Il-12 Production App 20200360359 - Moffat; David Festus Charles ; et al. | 2020-11-19 |
| Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]- -3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof Grant 10,370,332 - Pintat , et al. | 2019-08-06 |
| Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2h)-yl]- -3,5- Difluorophenyl}ethyl]-l-alaninate Or A Salt,hydrate Or Solvate Thereof App 20180127371 - Pintat; Stephane ; et al. | 2018-05-10 |
| Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]- -3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof Grant 9,896,417 - Pintat , et al. February 20, 2 | 2018-02-20 |
| HDAC inhibitors Grant 9,725,407 - Davidson , et al. August 8, 2 | 2017-08-08 |
| Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters Grant 9,636,409 - Drummond , et al. May 2, 2 | 2017-05-02 |
| 2-aminopyrazine derivatives as CSF-1R kinase inhibitors Grant 9,604,940 - Davies , et al. March 28, 2 | 2017-03-28 |
| Tert-butyl N-[2-ethyl]-l-alaninate Or A Salt,hydrate Or Solvate Thereof App 20160297760 - Pintat; Stephane ; et al. | 2016-10-13 |
| Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]- -3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof Grant 9,388,136 - Pintat , et al. July 12, 2 | 2016-07-12 |
| Benzamide Derivatives And Their Use As Hsp90 Inhibtors App 20160193200 - Donald; Alastair David Graham ; et al. | 2016-07-07 |
| Enzyme And Receptor Modulation App 20160151509 - Drummond; Alan Hastings ; et al. | 2016-06-02 |
| Hdac Inhibitors App 20160137594 - DAVIDSON; Alan Hornsby ; et al. | 2016-05-19 |
| Benzamide derivatives and their use as HSP90 inhibtors Grant 9,321,718 - Donald , et al. April 26, 2 | 2016-04-26 |
| Methods of treating lymphoma and rheumatoid arthritis with cyclopentyl (2S)-cyclohexyl[({6-[3-(hydroxyamino)-3-oxopropyl]pyridin-3-yl}methyl)ami- no]acetate Grant 9,273,003 - Davidson , et al. March 1, 2 | 2016-03-01 |
| 2-aminopyrazine Derivatives As Csf-1 R Kinase Inhibitors App 20150368210 - Davies; Stephen John ; et al. | 2015-12-24 |
| Enzyme inhibitors Grant 9,133,104 - Davidson , et al. September 15, 2 | 2015-09-15 |
| Tert-butyl N-[2-ethyl]-l-alaninate Or A Salt, Hydrate Or Solvate Thereof App 20150246883 - Pintat; Stephane ; et al. | 2015-09-03 |
| Hdac Inhibitors App 20140323531 - DAVIDSON; Alan Hornsby ; et al. | 2014-10-30 |
| Inhibitors of P38 map kinase Grant 8,778,953 - Moffat , et al. July 15, 2 | 2014-07-15 |
| Enzyme Inhibitors App 20140163042 - Davidson; Alan Hornsby ; et al. | 2014-06-12 |
| Enzyme Inhibitors App 20140155439 - Donald; Alastair David Graham ; et al. | 2014-06-05 |
| Enzyme And Receptor Modulation App 20140088159 - Drummond; Alan Hastings ; et al. | 2014-03-27 |
| Imaging Agents App 20140010762 - Charlton; Michael Hugh ; et al. | 2014-01-09 |
| Enzyme Inhibitors App 20130303576 - Donald; Alastair David Graham ; et al. | 2013-11-14 |
| Benzamide Derivatives And Their Use As Hsp90 Inhibtors App 20130143926 - Donald; Alastair David Graham ; et al. | 2013-06-06 |
| Adenine derivative as inhibitors of HSP90 for the treatment of cancer Grant 8,217,050 - Moffat , et al. July 10, 2 | 2012-07-10 |
| Enzyme Inhibitors App 20120149736 - Donald; Alastair David Graham ; et al. | 2012-06-14 |
| Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity Grant 8,148,531 - Davidson , et al. April 3, 2 | 2012-04-03 |
| IKK-beta serine-threonine protein kinase inhibitors Grant 8,003,695 - Moffat , et al. August 23, 2 | 2011-08-23 |
| Inhibitors of PLK App 20110190306 - Moffat; David Festus Charles ; et al. | 2011-08-04 |
| Hydroxamic acid derivatives as inhibitors of HDAC enzymatic activity Grant 7,973,181 - Davidson , et al. July 5, 2 | 2011-07-05 |
| Histone deacetylase inhibitors Grant 7,932,246 - Moffat , et al. April 26, 2 | 2011-04-26 |
| Substituted Thiopenecarboxamides As Ikk-beta Serine-, Threonine-protein Kinase Inhibitors App 20110046210 - Moffat; David Festus Charles ; et al. | 2011-02-24 |
| Inhibitors Of Ikk-beta Serine-theronine Protein Kinase App 20110039920 - Moffat; David Festus Charles ; et al. | 2011-02-17 |
| Inhibitors of P38 Map Kinase App 20110034520 - Moffat; David Festus Charles ; et al. | 2011-02-10 |
| Hydroxamates As Inhibitors Of Histone Deacetylase App 20100317678 - Moffat; David Festus Charles ; et al. | 2010-12-16 |
| Enzyme And Receptor Modulation App 20100317865 - Davidson; Alan Hornsby ; et al. | 2010-12-16 |
| P38 Map Kinase Inhibitors App 20100267774 - Moffat; David Festus Charles ; et al. | 2010-10-21 |
| Pteridine Derivatives As Polo-like Kinase Inhibitors Useful In The Treatment Of Cancer App 20100216802 - Moffat; David Festus Charles ; et al. | 2010-08-26 |
| Histone Deacetylase Inhibitors App 20100152155 - Moffat; David Festus Charles ; et al. | 2010-06-17 |
| Ikk-beta Serine-threonine Protein Kinase Inhibitors App 20100087515 - Moffat; David Festus Charles ; et al. | 2010-04-08 |
| Inhibitors Of IKK-Beta Serine-Threonine Protein Kinase App 20100069473 - Moffat; David Festus Charles ; et al. | 2010-03-18 |
| Adenine Derivative As Inhibitors Of Hsp90 For The Treatment Of Cancer App 20100035901 - Moffat; David Festus Charles ; et al. | 2010-02-11 |
| Hdac Inhibitors App 20100010010 - Davidson; Alan Hornsby ; et al. | 2010-01-14 |
| Hydroxamic Acid Derivatives As Inhibitors Of Hdac Enzymatic Activity App 20090298924 - Davidson; Alan Hornsby ; et al. | 2009-12-03 |
| Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity App 20090131461 - Davidson; Alan Hornsby ; et al. | 2009-05-21 |
| Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases Grant 7,012,076 - Moffat , et al. March 14, 2 | 2006-03-14 |
| 4,5-Disubstituted-2-aminopyrimidines App 20050171134 - Davis, Jeremy Martin ; et al. | 2005-08-04 |
| 4,5-Disubstituted-2-aminopyrimidines App 20040235876 - Davis, Jeremy Martin ; et al. | 2004-11-25 |
| 4.5-disubstituted-2-aminopyrimidines App 20030212269 - Davis, Jeremy Martin ; et al. | 2003-11-13 |
| Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases App 20030153755 - Moffat, David Festus Charles ; et al. | 2003-08-14 |
| Fused polycyclic 2-aminopyrimidine derivatives Grant 6,599,908 - Davis , et al. July 29, 2 | 2003-07-29 |
| 4,5-disubstituted-2-aminopyrimidines Grant 6,600,037 - Davis , et al. July 29, 2 | 2003-07-29 |
| 5-cyano-2-aminopyrimidine derivatives Grant 6,579,983 - Batchelor , et al. June 17, 2 | 2003-06-17 |
| 2-pyrimidineamine derivatives and processes for their preparation Grant 6,552,029 - Davis , et al. April 22, 2 | 2003-04-22 |
| 5-cyano-2-aminopyrimidine derivatives App 20020147339 - Batchelor, Mark James ; et al. | 2002-10-10 |
| Tryptophan derivatives App 20020115692 - Archibald, Sarah Catherine ; et al. | 2002-08-22 |
| Substituted 2-anilinopyrimidines useful as protein kinase inhibitors Grant 6,337,335 - Hutchings , et al. January 8, 2 | 2002-01-08 |
| Substituted 2-anilinopyrimidines useful as protein kinase inhibitors Grant 6,235,746 - Davis , et al. May 22, 2 | 2001-05-22 |
| Fused polycyclic 2-aminopyrimidine derivatives Grant 6,133,257 - Batchelor , et al. October 17, 2 | 2000-10-17 |
| 2-Pyrimidineamine derivatives and processes for their preparation Grant 6,114,333 - Davis , et al. September 5, 2 | 2000-09-05 |
| Substituted 2-pyrimidineamines and processes for their preparation Grant 6,093,716 - Davis , et al. July 25, 2 | 2000-07-25 |
| Fused polycyclic 2-aminopyrimidine derivatives Grant 6,057,329 - Davis , et al. May 2, 2 | 2000-05-02 |
| Substituted 2-anilinopryimidines useful as protein kinase inhibitors Grant 6,048,866 - Hutchings , et al. April 11, 2 | 2000-04-11 |
| Substituted 2-anilinopyrimidines useful as protein kinase inhibitors Grant 5,958,935 - Davis , et al. September 28, 1 | 1999-09-28 |
| 5-aminopyrazoles useful as tyrosine kinase inhibitors Grant 5,922,741 - Davis , et al. July 13, 1 | 1999-07-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 